Riskpilot← Back to searchSign inGet full accessNormedic AB
ABDissolvedOrg 5565744934General medical practice activities · NACE 8621Est. 19990 employees
Revenue 2021
SEK 0
EBITDA margin
—
-126% vs 2020
Equity ratio
95.8%
Financial strength
Net profit 2021
SEK 61K
-25% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -20K | -126% |
| Net profit | SEK 61K | -25% |
| Total assets | SEK 1,5M | -6% |
| Equity | SEK 1,4M | +3% |
| Employees | 0 | — |
Legal name
Normedic AB
Org number
5565744934
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 augusti 1999
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-08-31
Financial year
January – December
Company purpose
Bolaget skall bedriva läkarpraktik, handel med konst och antikviteter, förvaltning av fast och lös egendom ävensom idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | — | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −9 | −9 | 0 | 76 | −20 |
| Depreciation & amort. | −0 | −0 | — | −0 | −0 |
| EBIT | −9 | −9 | 0 | 76 | −20 |
| Net financials | 33 | 37 | — | 28 | 10 |
| Profit before tax | 23 | 28 | 0 | 106 | 78 |
| Tax | −5 | −6 | — | −25 | −17 |
| Net profit | 18 | 22 | — | 81 | 61 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 1 442 | 1 484 | — | 1 554 | 1 456 |
| Equity | 1 229 | 1 251 | — | 1 354 | 1 395 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 123 | 143 | — | 112 | 62 |
| Total debt | 123 | 143 | — | 112 | 62 |
EBITDA margin
-2000000.0%
This company
15.8%
Market median
-12658328% vs market
20172021
Equity ratio
95.8%
This company
38.2%
Market median
+151% vs market
20172021
Return on equity
4.4%
This company
18.4%
Market median
-76% vs market
20172021
Net profit margin
6100000.0%
This company
8.1%
Market median
+75308542% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PE Audit | Audit | 2021 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
| Former (2) | ||
| Deputy Board Member | 2021 – 2021 | |
| Board of Directors | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Normedic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Erik Gillmert | Audit | 0 companies |
| Leif Gustav Andersson | Deputy Board Member | 0 companies |
| Inger Margareta Dahle | Deputy Board Member | 0 companies |
| Erna Margareta Norberg | Deputy Board Member | 0 companies |
| Bengt Junior Niklas Nygårds | Board of Directors | 0 companies |
| David Norberg | Board of Directors | 0 companies |
| Ulrika Margareta Ahlholm | Deputy Board Member | 0 companies |